Hillstream BioPharma Inc. (HILS)
NASDAQ: HILS
· Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM
Hillstream BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -8.69M | -8.97M | -8.25M | -6.88M | -5.22M | -3.63M | -3.09M | -3.21M | -4.14M | -3.92M | -2.82M |
Interest Income | 94.9K | 66.45K | 32.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.61M | -8.92M | -8.22M | -8.47M | -4.25M | -2.98M | -2.9M | -2.21M | -5.96M | -5.52M | -3.96M |
Net Income | -1.6B | -1.6B | -1.6B | -1.6B | -4.25M | -2.98M | -2.9M | -2.21M | -5.96M | -5.52M | -3.96M |
Selling & General & Admin | 5.44M | 5.38M | 5.23M | 4.6M | 3.66M | 2.6M | 1.84M | 1.37M | 1.57M | 1.51M | 1.08M |
Research & Development | 3.25M | 3.59M | 3.02M | 2.28M | 1.55M | 1.04M | 1.25M | 1.84M | 2.27M | 2.13M | 1.45M |
Other Expenses | n/a | n/a | n/a | n/a | 2.81M | 2.74M | 2.47M | 1.83M | -1.14M | -1.09M | -821.54K |
Operating Expenses | 8.69M | 8.97M | 8.25M | 6.88M | 5.22M | 3.63M | 3.09M | 3.21M | 3.85M | 3.63M | 2.53M |
Interest Expense | 16.15K | 12.65K | 6.14K | 1.59M | 1.85M | 2.09M | 2.27M | 831.28K | 678.95K | 504.49K | 315.59K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.69M | 8.97M | 8.25M | 6.88M | 5.22M | 3.63M | 3.09M | 3.21M | 3.85M | 3.63M | 2.53M |
Income Tax Expense | 1.59B | 1.59B | 1.59B | 1.59B | 258.37K | 494.19K | 683.09K | 831.28K | 389.75K | 215.29K | 26.39K |
Shares Outstanding (Basic) | 17.29M | 14.95M | 11.51M | 11.23M | 11.53M | 11.57M | 10.57M | 10.3M | 10.3M | 11.23M | 11.23M |
Shares Outstanding (Diluted) | 17.29M | 14.95M | 11.51M | 11.23M | 11.53M | 11.57M | 10.57M | 10.3M | 10.3M | 11.23M | 11.23M |
EPS (Basic) | -142.6 | -142.67 | -142.65 | -142.7 | -0.36 | -0.26 | -0.26 | -0.18 | -0.54 | -0.49 | -0.35 |
EPS (Diluted) | -142.6 | -142.67 | -142.65 | -142.7 | -0.36 | -0.26 | -0.26 | -0.18 | -0.54 | -0.49 | -0.35 |
EBITDA | -8.6M | -8.91M | -8.21M | -6.88M | -2.4M | -894.33K | -624.66K | -1.38M | -5.28M | -5.01M | -3.64M |
EBIT | -10.07B | -10.06B | -10.06B | -10.06B | -496.71K | -878.51K | -2.06M | -4.01M | -4.89M | -4.8M | -3.62M |
Depreciation & Amortization | -1.47M | -1.48M | -1.42M | -1.4M | 2.99M | 2.88M | 2.53M | 1.83M | -1.14M | -1.09M | -821.54K |